UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UBS Group
UBS
|
+$1.48B |
| 2 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$690M |
| 3 |
VanEck Junior Gold Miners ETF
GDXJ
|
+$588M |
| 4 |
Truist Financial
TFC
|
+$532M |
| 5 |
VanEck Gold Miners ETF
GDX
|
+$278M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.3B |
| 2 |
Alibaba
BABA
|
+$771M |
| 3 |
AABA
Altaba Inc
AABA
|
+$759M |
| 4 |
STI
SunTrust Banks, Inc.
STI
|
+$503M |
| 5 |
BPL
Buckeye Partners, L.P.
BPL
|
+$467M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.82% |
| 2 | Financials | 7.38% |
| 3 | Healthcare | 6.65% |
| 4 | Consumer Discretionary | 5.46% |
| 5 | Industrials | 5.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AXDX
2951
DELISTED
Accelerate Diagnostics
AXDX
| $3.5M | ﹤0.01% |
20,737
+4,542
| +28% | +$750K |
|
|
GBAB
2952
Guggenheim Taxable Municipal Bond & Investment Grade Debt Trust
GBAB
$389M
| $3.5M | ﹤0.01% |
147,967
+17,701
| +14% | +$421K |
|
2953
PUT
ZTO Express
ZTO
$17.9B
| $3.5M | ﹤0.01% |
150,000
| – | – |
|
|
XIFR
2954
XPLR Infrastructure LP
XIFR
$1.08B
| $3.49M | ﹤0.01% |
66,326
+3,211
| +5% | +$167K |
|
|
RDS.A
2955
CALL
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $3.48M | ﹤0.01% |
59,000
-1,300
| -2% | -$75.9K |
|
2956
Credit Acceptance
CACC
$6.08B
| $3.48M | ﹤0.01% |
7,865
-49
| -0.6% | -$21.6K |
|
2957
Affiliated Managers Group
AMG
$9.76B
| $3.48M | ﹤0.01% |
41,045
-4,070
| -9% | -$334K |
|
2958
Varonis Systems
VRNS
$5B
| $3.48M | ﹤0.01% |
134,202
+37,254
| +38% | +$885K |
|
2959
Sonoco
SON
$5.74B
| $3.48M | ﹤0.01% |
56,310
+13,014
| +30% | +$770K |
|
|
HES
2960
PUT
DELISTED
Hess
HES
| $3.47M | ﹤0.01% |
52,000
-60,000
| -54% | -$3.93M |
|
2961
Innospec
IOSP
$2.28B
| $3.47M | ﹤0.01% |
33,563
-1,948
| -5% | -$186K |
|
|
MRCC
2962
DELISTED
Monroe Capital Corp
MRCC
| $3.47M | ﹤0.01% |
319,377
+298
| +0.1% | +$3.27K |
|
|
CXO
2963
DELISTED
CONCHO RESOURCES INC.
CXO
| $3.47M | ﹤0.01% |
39,615
-285,560
| -88% | -$20.6M |
|
2964
Ethan Allen Interiors
ETD
$603M
| $3.46M | ﹤0.01% |
181,771
+155,478
| +591% | +$2.9M |
|
2965
Mueller Water Products
MWA
$4.16B
| $3.46M | ﹤0.01% |
288,895
+71,363
| +33% | +$815K |
|
2966
CALL
TotalEnergies
TTE
$190B
| $3.46M | ﹤0.01% |
62,500
-87,500
| -58% | -$4.63M |
|
2967
Nu Skin
NUS
$267M
| $3.45M | ﹤0.01% |
84,221
+56,832
| +207% | +$2.32M |
|
2968
WisdomTree Global ex-U.S. Quality Growth Fund
DNL
$501M
| $3.44M | ﹤0.01% |
104,604
-650
| -0.6% | -$20.1K |
|
2969
Vanguard Russell 3000 ETF
VTHR
$4.85B
| $3.44M | ﹤0.01% |
23,500
-250
| -1% | -$35K |
|
2970
FNB Corp
FNB
$6.75B
| $3.44M | ﹤0.01% |
270,851
+140,551
| +108% | +$1.72M |
|
2971
CALL
Twilio
TWLO
$36.6B
| $3.44M | ﹤0.01% |
35,000
-41,900
| -54% | -$4.28M |
|
|
RMI
2972
RiverNorth Opportunistic Municipal Income Fund
RMI
$101M
| $3.44M | ﹤0.01% |
151,577
+15,356
| +11% | +$339K |
|
|
RAVN
2973
DELISTED
Raven Industries Inc
RAVN
| $3.44M | ﹤0.01% |
99,758
+17,688
| +22% | +$603K |
|
2974
CALL
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$14.7B
| $3.44M | ﹤0.01% |
30,000
-310,000
| -91% | -$35M |
|
2975
CRISPR Therapeutics
CRSP
$5.17B
| $3.44M | ﹤0.01% |
56,393
+10,936
| +24% | +$597K |
|
Similar funds
UBS Group's Q4 2019 Portfolio in Review
As of Q4 2019, UBS Group held 8,864 positions worth $287B, up 11% from $260B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
UBS Group's Q4 2019 filing shows 808 new, 4,306 increased, 2,684 reduced and 688 closed positions. Its largest new stake was Bristol-Myers Squibb Company Contingent Value Rights: 5,302,748 shares worth $16M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.3B.
By sector, the portfolio is most concentrated in Technology at 9.8% of assets, up from 9.5% a quarter earlier, followed by Financials and Healthcare.
- UBS Group's largest Q4 2019 buy was Bristol-Myers Squibb Company Contingent Value Rights: 5,302,748 shares worth $16M.
- UBS Group added most to UBS Group in Q4 2019, an estimated $1.48B increase.
- UBS Group's biggest Q4 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.3B.
- UBS Group fully exited Altaba Inc in Q4 2019, selling an estimated $759M.
- UBS Group's ten largest holdings make up 13% of its $287B portfolio in Q4 2019.
- UBS Group opened 808 new positions and closed 688 in Q4 2019.
- UBS Group's portfolio value rose 11% quarter-over-quarter to $287B.
Based on UBS Group's 13F filing for Q4 2019, filed 14 Feb 2020.